Form 4 for CV CapsoVision, Inc
Accepted 2026-05-06 12:50:57 ET · period of report 2026-05-04 · accession 0002074105-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-06 12:50 | 2026-05-04+ | CV | Atkinson Douglas Patrick | Head of Gbl Sales | M - OptEx | $0.4163 | +107.4K | 107.4K | New | +$44.7K |
| DM | 2026-05-06 12:50 | 2026-05-04+ | CV | Atkinson Douglas Patrick | Head of Gbl Sales | M - OptEx | $0.00 | -107.4K | 18.8K | -85% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-04 | M | A | 36,036 | $0.2863 | 36,036 | D | — | — | (F1) The exercise price reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. (F2) The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. |
| 2 | Common | Common Stock | 2026-05-04 | M | A | 30,030 | $0.3663 | 66,066 | D | — | — | (F1) The exercise price reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. (F2) The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. |
| 3 | Common | Common Stock | 2026-05-04 | M | A | 6,505 | $0.5661 | 72,571 | D | — | — | (F1) The exercise price reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. (F2) The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. |
| 4 | Common | Common Stock | 2026-05-05 | M | A | 34,786 | $0.5661 | 107,357 | D | — | — | (F1) The exercise price reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. (F2) The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. |
| 5 | Derivative | Stock Option (right to buy) | 2026-05-04 | M | D | 36,036 | $0.00 | 0 | D | $0.2863 · — to 2026-11-09 | 36,036 Common Stock | (F1) The exercise price reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. (F3) The option is fully vested and exercisable as of the transaction date. (F2) The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. |
| 6 | Derivative | Stock Option (right to buy) | 2026-05-04 | M | D | 30,030 | $0.00 | 0 | D | $0.3663 · — to 2031-06-14 | 30,030 Common Stock | (F1) The exercise price reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. (F3) The option is fully vested and exercisable as of the transaction date. (F2) The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. |
| 7 | Derivative | Stock Option (right to buy) | 2026-05-04 | M | D | 6,505 | $0.00 | 53,555 | D | $0.5661 · — to 2033-07-23 | 6,505 Common Stock | (F1) The exercise price reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. (F4) The option is partially vested and exercisable as of the transaction date. (F2) The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. (F2) The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. |
| 8 | Derivative | Stock Option (right to buy) | 2026-05-05 | M | D | 34,786 | $0.00 | 18,769 | D | $0.5661 · — to 2033-07-23 | 34,786 Common Stock | (F1) The exercise price reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. (F4) The option is partially vested and exercisable as of the transaction date. (F2) The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. (F2) The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering. |